Johnson & Johnson has released its Q1 2019 financial results.
- Worldwide sales increased .1% to $20 billion
- Consumer sales, at $3.3 billion, decreased 2.4%
“Our strong first quarter results reflect continued underlying operational sales and adjusted EPS growth,” said chairman and CEO Alex Gorsky. “At the same time, we remain focused on investing in innovative technologies and platforms that will make a meaningful difference in the lives of patients around the world. I am proud of our global colleagues’ collective efforts to deliver our long-term goals and our ability to create value for all of our stakeholders.”
The Goal for 2019: Just Keep Growing
“The strength of our first-quarter results reinforces the confidence we have in our outlook for 2019," said Joe Wolk, executive vice president and chief financial officer. “Utilizing the collective and individual skills of our 135,000 global Johnson & Johnson colleagues, we continue to optimize our portfolio with discipline and make investments across the enterprise that position us to continue achieving long-term, sustainable growth and deliver significant value to patients, healthcare providers and shareholders.”